<DOC>
	<DOCNO>NCT00270517</DOCNO>
	<brief_summary>This study compare efficacy , safety tolerability EDP-420 versus another oral antibiotic treatment community acquire pneumonia</brief_summary>
	<brief_title>Comparative Study EDP-420 Versus Another Antibiotic Treatment Community Acquired Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Telithromycin</mesh_term>
	<criteria>Recent respiratory illness sign symptoms chest Xray consistent diagnosis communityacquired pneumonia . Suitable candidate oral antibiotic therapy able swallow large capsule intact If female , must nonlactating risk pregnancy Other infection Other pulmonary disease requirement multiple antibacterial medication long duration therapy History hypersensitivity , allergic adverse reaction macrolide , ketolide , azalide streptogramins Evidence uncontrolled clinically significant disease , malignancy , abnormality Requirement parenteral antimicrobial therapy treatment pneumonia Currently receive likely receive know inhibitor inducer cytochrome P450 mediate drug metabolism Immunocompromised subject</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2006</verification_date>
</DOC>